ICL And Lavie Bio Leverage AI To Make Significant Advancement In Development Of Yield Increasing Bio-Stimulants

7/17/24 8:03:34 AM ET

$EVGN

$ICL

Agricultural Chemicals

Industrials

Agricultural Chemicals

Industrials

Get the next $EVGN alert in real time by email

More than one dozen novel microbes identified for row crops suffering from extreme weather conditions

TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and subsidiary of Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), today announced a significant milestone in their collaboration to develop bio-stimulant solutions for key row crops facing various abiotic stresses. By leveraging artificial intelligence (AI), Lavie Bio has computationally identified more than a dozen novel microbial candidates believed to have commercial viability as bio-stimulants for crops grown under extreme weather conditions, including drought. While this process can normally take several years, the collaboration achieved success within its first 12 months – thanks to Lavie Bio's proprietary Biology Driven Design (BDD) technology platform.

Get the next $EVGN alert in real time by email

Company	Date	Price Target	Rating	Analyst
ICL Group Ltd. $ICL	1/12/2024	$6.50 → $4.00	Overweight → Underweight	Barclays
ICL Group Ltd. $ICL	11/14/2023	$7.00 → $6.50	Equal Weight → Overweight	Barclays
ICL Group Ltd. $ICL	5/18/2023		Buy → Neutral	BofA Securities
ICL Group Ltd. $ICL	6/1/2022	$12.00	Equal Weight	Barclays
ICL Group Ltd. $ICL	2/14/2022	$9.00 → $10.00	Equal-Weight	Morgan Stanley
ICL Group Ltd. $ICL	12/6/2021	$7.00 → $9.00	Equal-Weight	Morgan Stanley
Evogene Ltd $EVGN	11/24/2021	$8.00 → $7.00	Outperform	RBC Capital
Evogene Ltd $EVGN	10/8/2021	$7.00	Buy	ROTH Capital

ICL And Lavie Bio Leverage AI To Make Significant Advancement In Development Of Yield Increasing Bio-Stimulants

Chat with this insight

Recent Analyst Ratings for
$EVGN
$ICL

$EVGN
$ICL
Leadership Updates

Live Leadership Updates

ICL Recognized by Fortune as a Company That is Changing the World

ICL Makes Significant Expansion in China, with Opening of New Food Specialty Plant

Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation

$EVGN
$ICL
Large Ownership Changes

This live feed shows all institutional transactions in real time.

Amendment: SEC Form SC 13G/A filed by ICL Group Ltd.

Amendment: SEC Form SC 13G/A filed by Evogene Ltd

SEC Form SC 13G filed by Evogene Ltd

$EVGN
$ICL
Financials

Live finance-specific insights

Israel Corp. Reports Results for Third Quarter of 2024

Evogene Reports Third Quarter 2024 Financial Results

ICL Reports Third Quarter 2024 Results

$EVGN
$ICL
Market Insights

Live Market Insights

Evogene shares are trading lower after the company announced a 1-for-10 reverse share split.

Reported Earlier, Evogene Announces 1-for-10 Reverse Share Split